Production of transgenic rabbits using centrifuged pronuclear zygotes.
Superovulation of female rabbits was induced by subcutaneous injection(s) of porcine FSH. Zygotes were recovered 17 to 19 hr after hCG injection and were classified into two categories under a microscope equipped with Nomarski interference-contrast optics at x 200 magnification: (A) zygotes with clearly visible pronuclei, or (B) zygotes with visualized pronuclei after 10 min centrifugation at 12,000 x g. No significant difference between strains was found in the proportion of category-A zygotes (JW 72.6% vs NZW 79.3%). Pronuclei of category-A zygotes were located in the center of the cytoplasm, and the pronuclei of category-B zygotes were slightly moved by centrifugation toward the mass of cytoplasmic lipid droplets. Exogenous DNA solution (5 microg/ml of fusion gene composed of bovine alphaS1-casein promoter and human growth hormone structural gene) was microinjected into the pronucleus of the JW zygotes. The pronucleus of category-A zygotes with a mean volume of 7.4 pl swelled up to 16.6 pl (132% increase), while that of category-B zygotes with a mean volume of 6.1 pl swelled up to 15.9 pl (148% increase). Nevertheless, similar proportions of category-A and category-B zygotes developed into offspring after transfer to recipient females (11.1 and 11.2%, respectively). The efficiency to produce hGH-carrying transgenic rabbits was 0.9% (2/235) from category-A zygotes and 0.5% (1/215) from category-B zygotes (P>0.05). To date, transgenic rabbits have been produced without centrifugation of pronuclear zygotes. However approximately 25% of fertilized rabbit zygotes can be used for DNA microinjection after they have been centrifuged to visualize their pronuclei.
Hirabayashi
M
M
YS New Technology Institute Inc, Shimotsuga-Gun, Tochigi, Japan.
Hirao
M
M
Takahashi
R
R
Kimura
K
K
Hirasawa
K
K
Ueda
M
M
Hochi
S
S
D000818:Animals; D030801:Animals, Genetically Modified / Q000196:embryology; D002498:Centrifugation / Q000662:veterinary; D004247:DNA / Q000008:administration & dosage; D005260:Female; D018014:Gene Transfer Techniques / Q000662:veterinary*; D008845:Microinjections / Q000662:veterinary; D016133:Polymerase Chain Reaction / Q000662:veterinary; D011817:Rabbits / Q000196:embryology* / Q000235:genetics; D013047:Specific Pathogen-Free Organisms; D013480:Superovulation; D015053:Zygote / Q000254:growth & development*; D017388:Zygote Intrafallopian Transfer / Q000662:veterinary
D004247:DNA